Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, Debomoy K. Lahiri, Nigel H. Greig
Topics & Concepts
IncretinMedicineType 2 Diabetes MellitusDiabetes mellitusDiseaseAgonistType 2 diabetesWeight lossDrugObesityExenatideBioinformaticsPharmacologyReceptorNeuroscienceInternal medicineEndocrinologyBiologyDiabetes Treatment and ManagementApelin-related biomedical researchPharmacology and Obesity Treatment